NCT04985357 2024-11-25Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsTravera IncWithdrawn
NCT05418387 2024-11-25A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in ArizonaUniversity of ArizonaPhase NA Withdrawn
NCT04158700 2020-02-19A Study of LY3200882 and Pembrolizumab in Participants With Advanced CancerEli Lilly and CompanyPhase 1/2 Withdrawn
NCT01441388 2011-12-20A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.PfizerPhase 1 Withdrawn